Overview

Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine

Status:
Recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of eptinezumab to prevent migraine in patients with chronic migraine
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S